Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy analysis of autologous myoblast sheet for cardiomyopathy
jRCT1050200090Completed
- Sponsor
- The University of Osaka
- Start
- May 2019
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous myoblast sheet in heart failure (HF) and Cardiomyopathies, sponsored by The University of Osaka. Primary endpoint: Heart failure parameters. Started May 2019; status: completed.
02
Drugs
autologous myoblast sheet
03
Conditions
heart failure (HF)Cardiomyopathies
Beyond the preview
Go deeper on jRCT1050200090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1050200090.